MwanzoTAK • NYSE
add
Takeda Pharmaceutical Co Ltd
$ 14.44
Baada ya Saa za Kazi:(0.97%)-0.14
$ 14.30
Imefungwa: 8 Ago, 19:56:15 GMT -4 · USD · NYSE · Kanusho
Bei iliyotangulia
$ 14.36
Bei za siku
$ 14.38 - $ 14.49
Bei za mwaka
$ 12.80 - $ 15.53
Thamani ya kampuni katika soko
45.93B USD
Wastani wa hisa zilizouzwa
4.53M
Uwiano wa bei na mapato
49.23
Mgao wa faida
4.61%
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (JPY) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 1.11T | -8.39% |
Matumizi ya uendeshaji wa biashara | 535.14B | -15.12% |
Mapato halisi | 124.24B | 30.44% |
Kiwango cha faida halisi | 11.23 | 42.51% |
Mapato kwa kila hisa | — | — |
EBITDA | 368.50B | -3.72% |
Asilimia ya kodi ya mapato | 17.49% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (JPY) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 350.01B | -56.48% |
Jumla ya mali | 14.00T | -13.70% |
Jumla ya dhima | 7.14T | -15.31% |
Jumla ya hisa | 6.87T | — |
hisa zilizosalia | 1.56B | — |
Uwiano wa bei na thamani | 0.00 | — |
Faida inayotokana na mali | 3.31% | — |
Faida inayotokana mtaji | 3.90% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (JPY) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 124.24B | 30.44% |
Pesa kutokana na shughuli | 215.42B | 26.49% |
Pesa kutokana na uwekezaji | -33.19B | 78.82% |
Pesa kutokana na ufadhili | -214.90B | -167.92% |
Mabadiliko halisi ya pesa taslimu | -35.10B | -110.11% |
Mtiririko huru wa pesa | 99.91B | -14.31% |
Kuhusu
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
12 Jun 1781
Tovuti
Wafanyakazi
47,455
